- Global Pharma News & Resources

US Hemato Oncology Testing Market Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021 – 2027 | Covid-19 Impact Analysis

Pune, Maharashtra, India, February 2 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Hemato Oncology Testing Market is valued at USD 2.50 Billion in 2018 and expected to reach USD 6.45 Billion by 2025 with the CAGR of 14.47% over the forecast period.

Increasing prevalence of blood related disorders including leukemia, lymphoma, etc. is likely to boost the growth of US Hemato Oncology Testing Market.

Scope of Hemato Oncology Testing Market Report:

Hemato oncology testing includes the analysis of blood disorders in the field of medical such as iron deficiency anemia, hemophilia, sickle cell disease, leukemias and lymphomas as well as cancers of other organs. The term hematology is often combined with oncology, where both hematologists and oncologists work together to treat these types of serious diseases for the better treatment of a cancer of the blood and bone marrow including leukemia and lymphoma. Technological advncements with precise use of information will make the entire hemato oncology testing relibale and effective.The part of hematological malignancies is hepful in the diagnosis and treatment of cancers of the bone marrow, blood and lymph nodes.

Get Sample of This Report@

US Hemato Oncology Testing market report is segmented on the basis of type, application and regional & country level. Based upon type, US hemato oncology testing market is segmented into leukemia testing, acute myeloid testing, multiple myeloma testing and other. On the basis of application, US hemato oncology testing market is classified into clinical laboratories and hospitals.

The regions covered in this US Hemato Oncology Testing Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of US hemato oncology testing market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for US Hemato Oncology Testing Market Report– Some major key players for US Hemato Oncology Testing market are Hoffmann-La Roche, Abbott Laboratories, Thermo Fisher Scientific, QIAGEN N.V., Bio-Rad Laboratories, Illumina, Molecular MD, Invivoscribe, Asuragen, Adaptive Biotechnologies, ArcherDx, ARUP Laboratories and others.

Rising Incidences of Hematological Malignancies is Expected to Grow the US Hemato Oncology Testing Market.- The demand for hemato oncology testing is anticipated to witness a high growth owing to the rising incidences of blood cancer cases and people are inclined towards an early detection of serious diseases through adopting analytical treatments such as hemato oncology testing. US spending on cancer medicines was reached of about USD133 billion with therapeutic and supportive care use in 2017. Similarly, rapid technological advancements is responsible for the detail analysis of the blood diseases, this has enabled the development of more effective approaches directed against the complex molecular pathways. These are some key factors supplementing the growth of hemato oncology testing market. Hematological malignancies accounted for about 8 to 9% of all cancers and became the fifth most frequently diagnosed cancer around the world. In 2018, about 437,033 new cases of Leukemia were diagnosed and USly cancer burden is expected to have rise to 18.1 million new cases and 9.6 million deaths. However, complex regulatory requirements and shortage of expert staff to handle the overall testing process may obstruct the growth of this market.

This report split US into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in US Hemato Oncology Testing Market. 

Key Benefits for Hemato Oncology Testing Market Reports

US market report covers in-depth historical and forecast analysis. US market research report provides detail information about Market Introduction, Market Summary, US market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. US market report helps to identify opportunities in market place. US market report covers extensive analysis of emerging trends and competitive landscape.

 US Hemato Oncology Testing Market Segmentation:–

 By Type:

Leukemia Testing Acute Myeloid Testing Multiple Myeloma Testing Other

By Application:

Clinical Laboratories Hospitals

By Region

North America

o U.S.

o Canada

o Mexico


o UK

o France

o Germany

o Russia

o Rest of Europe


o China

o South Korea

o India

o Japan

o Rest of Asia-Pacific


o Latin America

o Middle East

o Africa

North America is Expected to Dominate the Hemato Oncology Testing Market.- North America is expected to account for the largest share of the US  hemato oncology testing market over the forecast period. Growing prevalence of oncologic cases in this region and continuous evolvement of technological advancements in diagnostics and testing has lifted the growth of hemato oncology testing market in recent years. There were around 327,520 and 95,874 people are living with leukemia & myeloma in the US respectively. In 2014, approximately 52,380 people were diagnosed with leukemia. There are an estimated 95,874 people either living with, or in remission from, myeloma in the US. Asia pacific region is rapidly growing from the last few years in hemato oncology testing market due to favorable government initiatives to increase the awareness regarding blood related disorders and therapies. These are some factors are influencing the growth of the market during the forecast period in this region.

Hemato Oncology Testing Market Key Players:
• Hoffmann-La Roche
• Abbott Laboratories
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Illumina
• Molecular MD
• Invivoscribe
• Asuragen
• Adaptive Biotechnologies
• ArcherDx
• ARUP Laboratories
• others

This comprehensive report will provide:
• Enhance your strategic decision making
• Assist with your research, presentations and business plans
• Show which emerging market opportunities to focus on
• Increase your industry knowledge
• Keep you up-to-date with crucial market developments
• Allow you to develop informed growth strategies
• Build your technical insight
• Illustrate trends to exploit
• Strengthen your analysis of competitors
• Provide risk analysis, helping you avoid the pitfalls other companies could make
• Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the US & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the US market and what are the market shares of each region in the overall market in 2017?
• How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
• Which region has more opportunities?

Table of Content

1. Chapter – Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 

2. Chapter – US Hemato Oncology Testing Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. US Hemato Oncology Testing Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Hemato Oncology Testing Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 

3. Chapter – US Hemato Oncology Testing Market Overview: Quantitative Analysis
3.1. US Hemato Oncology Testing Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. US Hemato Oncology Testing Market Revenue Market Share (%), 2014- 2025
3.3. US Hemato Oncology Testing Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. US Hemato Oncology Testing Market Sales Market Share (%), 2014- 2025

4. Chapter – US Hemato Oncology Testing Market Analysis: By Type

5. Chapter – US Hemato Oncology Testing Market Analysis: By Applications  


Complete Report Details @

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44 2038074155 or mail us at





Related Report:

This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 02-Feb-2021